PTTG3P and myelodysplastic syndrome: Importantly, PTTG3P levels in MDS cells were significantly lower than those seen in normal controls (Figure 7F), and patients with higher than the median level of PTTG3P showed longer OS than those with lower PTTG3P levels (Figure 7G).